Meet the Team

Jeremy is passionate about investing today for a healthier tomorrow and bringing tangible benefits to people across the world.

As a veteran in the life sciences/healthcare industry he has been actively supporting the commercialisation of healthcare innovations and helping entrepreneurs build their international businesses over the past 40 years.

Founder and Managing Partner of BioScience Managers, Jeremy brings his decades of international experience to our investment team, to support the identification of investment opportunities and in the strategic assessment of value creation options, in particular through M&A and expansion into new geographies. He actively supports portfolio companies through his executive and non-executive roles.

Over his career, Jeremy has successfully managed in excess of US$1billion in equity investments. He launched the first dedicated biotechnology fund for the Australian market and is a former head of the life science private equity team at Rothschild Asset Management, an early pioneer and significant investor in the sector. In his early career he founded the International Biochemicals Group which he successfully sold to Royal Dutch Shell. He has served on more than 40 boards of directors in the life science sector, in the UK, Europe, USA, Canada, Japan and Australia.

Jeremy received his MA in Natural Sciences from Trinity College in Dublin and was a research scientist at the Institute of Cancer Research from 1972 to 1973.

Avita Medical Ltd (Australia)

Adherium Ltd (Australia)

BioScience Managers Pty Ltd (Australia)

International Bioscience Managers Ltd (UK)

Bioscience Managers UK Ltd (UK)

Sea Dragon Ltd (New Zealand) (Alternate)

CRiL (Australia)

REX Bionics (Australia)

Smart Matrix Ltd (UK)